125 results on '"LEWY-TRENDA, IWONA"'
Search Results
2. Gene and protein expression of O-GlcNAc-cycling enzymes in human laryngeal cancer
3. Metallothionein 2A core promoter region genetic polymorphism and its impact on the risk, tumor behavior, and recurrences of sinonasal inverted papilloma (Schneiderian papilloma)
4. Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer—the relationship with regulatory hypoxia-inducible factor-1α expression, tumor invasiveness, and patient prognosis
5. Genetic polymorphism of metallothionein 2A and risk of laryngeal cancer in a Polish population
6. The effect of metallothionein 2A core promoter region single-nucleotide polymorphism on accumulation of toxic metals in sinonasal inverted papilloma tissues
7. The −5 A/G single-nucleotide polymorphism in the core promoter region of MT2A and its effect on allele-specific gene expression and Cd, Zn and Cu levels in laryngeal cancer
8. Suppression of contact hypersensitivity after repeated exposures of humans to low doses of solar simulated radiation
9. Elicitation of contact hypersensitivity after repeated suberythemal exposures of humans to solar simulated radiation: number of epidermal Langerhans cells
10. Gene/protein expression of CAPN1/2-CAST system members is associated with ERK1/2 kinases activity as well as progression and clinical outcome in human laryngeal cancer
11. The c.*229C > T gene polymorphism in 3′UTR region of the topoisomerase IIβ binding protein 1 gene and LOH in BRCA1/2 regions and their effect on the risk and progression of human laryngeal carcinoma
12. Expression of prostaglandin E 2 prostanoid receptor EP2 and interleukin-1βin laryngeal carcinoma – preliminary study
13. Expression of Th17 cell population regulatory cytokines in laryngeal carcinoma – Preliminary study
14. Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer—the relationship with regulatory hypoxia-inducible factor-1α expression, tumor invasiveness, and patient prognosis
15. Gene and protein expression of O-GlcNAc-cycling enzymes in human laryngeal cancer
16. Expression of cell adhesion molecules in laryngeal carcinoma – preliminary analysis
17. [Nr 87] Expression of CTLA-4 and CCR3 in peripheral blood T cells of patients with squamous cell laryngeal carcinoma
18. [Nr 88] Diagnostic impact of the promoter methylation and E-cadherin and β-catenin gene and protein level expression in laryngeal carcinoma
19. Expression of CTLA-4 and Foxp3 in peripheral blood T cells of patients with squamous cell laryngeal carcinoma
20. Diagnostic impact of promoter methylation and E-cadherin gene and protein expression levels in laryngeal carcinoma
21. The c.*229C > T gene polymorphism in 3′UTR region of the topoisomerase IIβ binding protein 1 gene and LOH in BRCA1/2 regions and their effect on the risk and progression of human laryngeal carcinoma.
22. The role of tumor cells in the modification of T lymphocytes activity — the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I
23. Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor — the expression of the early CD69+, CD71+and the late CD25+, CD26+, HLA/DR + activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II
24. Ocena ekspresji Foxp3 i RORgamma t w jednojądrzastych komórkach krwi obwodowej u chorych z rakiem krtani jako wskaźników zaawansowania zmian nowotworowych – badania wstępne
25. Analiza ekspresji HIF-1α i COX-2 w utkaniu guza oraz korelacja ze stopniem inwazyjności zmian nowotworowych u chorych z rakiem krtani – badania wstępne
26. Analiza ekspresji JAK1, STAT3, STAT1 i SOCS1 w jednojądrzastych komórkach krwi obwodowej u chorych z rakiem krtani
27. The expression of SOCS1 and TLR4-NFkappaB pathway molecules in neoplastic cells as potential biomarker for the aggressive tumor phenotype in laryngeal carcinoma.
28. Secretion of inflammatory and regulatory cytokines and the association with depth and type of tumour invasion in patients with cancer of the larynx
29. Ekspresja transkrypcyjnego czynnika jądrowego NFκB w komórkach raka krtani – korelacja z ekspresją IL-10 oraz cechami kliniczno-morfologicznymi guza
30. Ekspresja wybranych antygenów aktywacji na limfocytach T u chorych z rakiem krtani a cechy kliniczno-morfologiczne guza
31. Wydzielanie wybranych cytokin przez monocytarne komórki krwi – korelacja z cechami kliniczno-morfologicznymi w raku krtani
32. Kliniczno-histopatologiczna charakterystyka przypadków brodawczaka odwróconego jam nosa i zatok przynosowych leczonych w Klinice Laryngologii Onkologicznej UM w Łodzi w latach 2002–2006 – przegląd najnowszego piśmiennictwa
33. Morfologiczna ocena nacieku nowotworowego oraz ekspresji metaloproteinazy błonowej macierzy zewnątrzkomórkowej typu I jako prognostyczny wskaźnik powstawania mikroprzerzutów w raku krtani
34. Expression of prostaglandin E2 prostanoid receptor EP2 and interleukin-1β in laryngeal carcinoma -- preliminary study.
35. Ekspresja β-kateniny w utkaniu nowotworowym raka krtani oraz znaczenie w ocenie inwazyjności zmian.
36. Kliniczno-morfologiczne znaczenie ekspresji genu i białka CCR3 w raku płaskonabłonkowym krtani.
37. The role of tumor cells in the modification of T lymphocytes activity - the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and...
38. Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor - the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+...
39. The expression of SOCS1 and TLR4-NFκB pathway molecules in neoplastic cells as potential biomarker for the aggressive tumor phenotype in laryngeal carcinoma.
40. Immunohistochemical expression of progesterone and estrogen receptors in meningiomas.
41. The − 5 A/G single-nucleotide polymorphism in the core promoter region of MT2A and its effect on allele-specific gene expression and Cd, Zn and Cu levels in laryngeal cancer.
42. Ocena ekspresji antygenów CD3+CD69+ i CD3+HLD/DR+ na limfocytach T krwi obwodowej u chorych z rakiem płaskonabłonkowym krtani.
43. Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer—the relationship with regulatory hypoxia-inducible factor-1α expression, tumor invasiveness, and patient prognosis
44. The c.*229C > T gene polymorphism in 3'UTR region of the topoisomerase IIβ binding protein 1 gene and LOH in BRCA1/2 regions and their effect on the risk and progression of human laryngeal carcinoma.
45. Expression of prostaglandin E2 prostanoid receptor EP2 and interleukin-1β in laryngeal carcinoma - preliminary study.
46. [Analysis of HIF-1α and COX-2 expression in tumor stroma and correlation with the degree of neoplasm invasiveness in laryngeal cancer--preliminary study].
47. [Expression of Foxp3 and RORgamma t in peripheral blood mononuclear cells in patients with laryngeal carcinoma as indicators of tumor stage--preliminary study].
48. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
49. Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II.
50. EGFR immunoexpression and peripheral blood cytokine secretion as potential biomarkers of tumor behavior in laryngeal squamous cell carcinoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.